Chlorion Pharma was a private biotechnology company based in Laval, Canada. The company focused on developing small molecule therapeutics for neurological disorders, particularly epilepsy and pain management. The company's approach involved correcting aberrant chloride homeostasis to quell neuronal hyperactivity.
Neurological disorders
CTI LSF I
Lead
Director
July 31, 2007
Liquidated in 2011
Series A
Chlorion Pharma's lead was intended to reduce neuronal hyperexcitability, offering potential treatments for conditions such as epilepsy and chronic pain
